Clinical use of abiraterone in the treatment of metastatic castration-resistant prostate cancer

Prostate cancer remains the most common type of cancer among men in the United States. Treatment for metastatic prostate cancer has improved significantly over the years with more and more agents improving overall survival. This review will address the pathophysiology of prostate cancer followed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Zobniw, Chrystia M, Causebrook, Alanna, Fong, Mei Ka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128838/
https://www.ncbi.nlm.nih.gov/pubmed/25157341
http://dx.doi.org/10.2147/RRU.S29003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128838/
https://www.ncbi.nlm.nih.gov/pubmed/25157341
http://dx.doi.org/10.2147/RRU.S29003

Ejemplares similares